Among them, vascular endothelial growth factor (VEGF), a key angiogenic factor, promotes neovascularization, increases vascular permeability, and regulates the expression of cytokines associated with fibrosis, thus driving the progression of IPF-ILD (11). Here, VEGFA is linked to interstitial lung disease.